Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 4
2010 4
2011 3
2013 1
2014 3
2015 2
2018 3
2019 2
2020 9
2021 5
2022 10
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.
Suárez-García I, Alejos B, Hernando V, Viñuela L, Vera García M, Rial-Crestelo D, Pérez Elías MJ, Albendín Iglesias H, Peraire J, Tiraboschi J, Díaz A, Moreno S, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. J Antimicrob Chemother. 2023 Jun 1;78(6):1423-1432. doi: 10.1093/jac/dkad102. J Antimicrob Chemother. 2023. PMID: 37099559 Free PMC article.
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis.
Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Zamorano L, Oliver A; GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group. Sastre-Femenia MÀ, et al. Lancet Reg Health Eur. 2023 Sep 19;34:100736. doi: 10.1016/j.lanepe.2023.100736. eCollection 2023 Nov. Lancet Reg Health Eur. 2023. PMID: 37753216 Free PMC article.
Fucosylated N-glycans as early biomarkers of COVID-19 severity.
Paton B, Herrero P, Peraire J, Del Pino A, Chafino S, Martinez-Picado J, Gómez-Bertomeu F, Rull A, Canela N, Suárez M. Paton B, et al. Among authors: gomez bertomeu f. Front Immunol. 2023 Jun 5;14:1204661. doi: 10.3389/fimmu.2023.1204661. eCollection 2023. Front Immunol. 2023. PMID: 37342334 Free PMC article.
Mitochondrial dysfunction, lipids metabolism, and amino acid biosynthesis are key pathways for COVID-19 recovery.
Sánchez A, García-Pardo G, Gómez-Bertomeu F, López-Dupla M, Foguet-Romero E, Buzón MJ, Almirante B, Olona M, Fernández-Veledo S, Vidal F, Chafino S, Rull A, Peraire J; COVIDOMICS Study Group. Sánchez A, et al. Among authors: gomez bertomeu f. iScience. 2023 Sep 19;26(10):107948. doi: 10.1016/j.isci.2023.107948. eCollection 2023 Oct 20. iScience. 2023. PMID: 37810253 Free PMC article.
Evaluation of five immunoassays and one lateral flow immunochromatography for anti-SARS-CoV-2 antibodies detection.
Montolio Breva S, Molina Clavero C, Gómez Bertomeu F, Picó-Plana E, Serrat Orús N, Palau Sánchez I, Mestre-Prad MT, Sans-Mateu MT. Montolio Breva S, et al. Among authors: gomez bertomeu f. Enferm Infecc Microbiol Clin (Engl Ed). 2022 Nov;40(9):489-494. doi: 10.1016/j.eimce.2020.12.007. Enferm Infecc Microbiol Clin (Engl Ed). 2022. PMID: 36336378 Free PMC article.
Immunoglobulins in COVID-19 pneumonia: from the acute phase to the recovery phase.
Peraire J, García-Pardo G, Chafino S, Sánchez A, Botero-Gallego M, Olona M, Espineira S, Reverté L, Skouridou V, Peiró ÓM, Gómez-Bertomeu F, Vidal F, O' Sullivan CK, Rull A. Peraire J, et al. Among authors: gomez bertomeu f. Eur J Med Res. 2024 Apr 6;29(1):223. doi: 10.1186/s40001-024-01824-5. Eur J Med Res. 2024. PMID: 38581072 Free PMC article.
48 results